Budezonid Ferring 9 mg tablete s podaljšanim sproščanjem Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

budezonid ferring 9 mg tablete s podaljšanim sproščanjem

ferring gmbh - budezonid - tableta s podaljšanim sproščanjem - budezonid 9 mg / 1 tableta - budezonid

Candecor 16 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

candecor 16 mg tablete

krka, d.d., novo mesto - cileksetilkandesartanat - tableta - cileksetilkandesartanat 16 mg / 1 tableta - kandesartan

Candecor 4 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

candecor 4 mg tablete

krka, d.d., novo mesto - cileksetilkandesartanat - tableta - cileksetilkandesartanat 4 mg / 1 tableta - kandesartan

Teysuno Evropska unija - slovenščina - EMA (European Medicines Agency)

teysuno

nordic group b.v. - tegafur, gimeracil, oteracil - Želodne neoplazme - antineoplastična sredstva - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Shingrix Evropska unija - slovenščina - EMA (European Medicines Agency)

shingrix

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - cepiva - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. uporaba shingrix mora biti v skladu z uradnimi priporočili.

Kinpeygo Evropska unija - slovenščina - EMA (European Medicines Agency)

kinpeygo

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, črevesne protivnetna / antiinfective agenti - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.